BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21252986)

  • 1. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.
    Yong AS; Stephens N; Weber G; Li Y; Savani BN; Eniafe R; Keyvanfar K; Kurlander R; Rezvani K; Barrett AJ
    Leukemia; 2011 Apr; 25(4):629-37. PubMed ID: 21252986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.
    Rezvani K; Yong AS; Savani BN; Mielke S; Keyvanfar K; Gostick E; Price DA; Douek DC; Barrett AJ
    Blood; 2007 Sep; 110(6):1924-32. PubMed ID: 17505014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bmi-1-green fluorescent protein-knock-in mice reveal the dynamic regulation of bmi-1 expression in normal and leukemic hematopoietic cells.
    Hosen N; Yamane T; Muijtjens M; Pham K; Clarke MF; Weissman IL
    Stem Cells; 2007 Jul; 25(7):1635-44. PubMed ID: 17395774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.
    Molldrem JJ; Lee PP; Kant S; Wieder E; Jiang W; Lu S; Wang C; Davis MM
    J Clin Invest; 2003 Mar; 111(5):639-47. PubMed ID: 12618518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation.
    Lukacs RU; Memarzadeh S; Wu H; Witte ON
    Cell Stem Cell; 2010 Dec; 7(6):682-93. PubMed ID: 21112563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lymphoblastic leukemia in children and SALL4 and BMI-1 gene expression.
    Hodeib H; El Amrousy D; Youssef A; Khedr R; Al-Asy H; Shabana A; Elnemr S; Abdelhai D
    Pediatr Res; 2023 Oct; 94(4):1510-1515. PubMed ID: 34782707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of BMI-1 and NANOG expression levels in survival prediction of pediatric acute lymphoblastic leukemia.
    Abdel-Khalek S; Saleh LM; Abdel-Aziz S; Hyder A; Abdel-Ghaffar H
    Hematol Transfus Cell Ther; 2021; 43(2):141-146. PubMed ID: 32278650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340.
    Jian X; He H; Zhu J; Zhang Q; Zheng Z; Liang X; Chen L; Yang M; Peng K; Zhang Z; Liu T; Ye Y; Jiao H; Wang S; Zhou W; Ding Y; Li T
    Mol Cancer; 2020 Jan; 19(1):20. PubMed ID: 32005118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells in chronic graft-versus-host disease.
    McManigle W; Youssef A; Sarantopoulos S
    Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Leukemia Stem Cells in the Bone Marrow Niche.
    Tasian SK; Bornhäuser M; Rutella S
    Biomedicines; 2018 Feb; 6(1):. PubMed ID: 29466292
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission.
    Hughes A; Yong ASM
    Front Immunol; 2017; 8():469. PubMed ID: 28484463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.
    Braun DA; Wu CJ
    Cancer J; 2017; 23(2):115-124. PubMed ID: 28410299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia.
    Peng HX; Liu XD; Luo ZY; Zhang XH; Luo XQ; Chen X; Jiang H; Xu L
    BMC Cancer; 2017 Jan; 17(1):76. PubMed ID: 28122538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells.
    Zhu L; Huang F; Deng G; Nie W; Huang W; Xu H; Zheng S; Yi Z; Wan T
    Onco Targets Ther; 2016; 9():5297-305. PubMed ID: 27601921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies.
    Takamatsu-Ichihara E; Kitabayashi I
    Int J Hematol; 2016 Jun; 103(6):634-42. PubMed ID: 27086351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century.
    Barrett AJ; Ito S
    Blood; 2015 May; 125(21):3230-5. PubMed ID: 25852053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant.
    Weber G; Gerdemann U; Caruana I; Savoldo B; Hensel NF; Rabin KR; Shpall EJ; Melenhorst JJ; Leen AM; Barrett AJ; Bollard CM
    Leukemia; 2013 Jul; 27(7):1538-47. PubMed ID: 23528871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for chronic myeloid leukemia.
    Pavlů J; Apperley JF
    Curr Hematol Malig Rep; 2013 Mar; 8(1):43-51. PubMed ID: 23275177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.
    Shen Q; Liu S; Hu J; Chen S; Yang L; Li B; Wu X; Ma Y; Yang J; Ma Y; Li Y
    Cancer Cell Int; 2012 Oct; 12(1):42. PubMed ID: 23067006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigens in chronic myeloid leukemia: implications for vaccine development.
    Smahel M
    Cancer Immunol Immunother; 2011 Dec; 60(12):1655-68. PubMed ID: 22033582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.